Iron toxicity in neurodegeneration

被引:151
作者
Nunez, Marco T. [1 ,2 ]
Urrutia, Pamela [1 ,2 ]
Mena, Natalia [1 ,2 ]
Aguirre, Pabla [1 ,2 ]
Tapia, Victoria [1 ,2 ]
Salazar, Julio [1 ,2 ]
机构
[1] Univ Chile, Dept Biol, Santiago, Chile
[2] Cell Dynam & Biotechnol Inst, Santiago, Chile
关键词
Iron homeostasis; Mitochondria dysfunction; GSH; Fe-S clusters; Neurodegeneration; MITOCHONDRIAL COMPLEX-I; METAL TRANSPORTER 1; TRANSFERRIN-BOUND IRON; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; LABILE IRON; A-BETA; TRANSCRIPTIONAL REGULATION;
D O I
10.1007/s10534-012-9523-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is an essential element for life on earth, participating in a plethora of cellular processes where one-electron transfer reactions are required. Its essentiality, coupled to its scarcity in aqueous oxidative environments, has compelled living organisms to develop mechanisms that ensure an adequate iron supply, at times with disregard to long-term deleterious effects derived from iron accumulation. However, iron is an intrinsic producer of reactive oxygen species, and increased levels of iron promote neurotoxicity because of hydroxyl radical formation, which results in glutathione consumption, protein aggregation, lipid peroxidation and nucleic acid modification. Neurons from brain areas sensitive to degeneration accumulate iron with age and thus are subjected to an ever increasing oxidative stress with the accompanying cellular damage. The ability of these neurons to survive depends on the adaptive mechanisms developed to cope with the increasing oxidative load. Here, we describe the chemical and thermodynamic peculiarities of iron chemistry in living matter, review the components of iron homeostasis in neurons and elaborate on the mechanisms by which iron homeostasis is lost in Parkinson's disease, Alzheimer's disease and other diseases in which iron accumulation has been demonstrated.
引用
收藏
页码:761 / 776
页数:16
相关论文
共 154 条
  • [1] Iron homeostasis in neuronal cells:: a role for IREGI -: art. no. 3
    Aguirre, P
    Mena, N
    Tapia, V
    Arredondo, M
    Núñez, MT
    [J]. BMC NEUROSCIENCE, 2005, 6 (1)
  • [2] Metals in Alzheimer's and Parkinson's diseases
    Barnham, Kevin J.
    Bush, Ashley I.
    [J]. CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (02) : 222 - 228
  • [3] MR evaluation of age-related increase of brain iron in young adult and older normal males
    Bartzokis, G
    Beckson, M
    Hance, DB
    Marx, P
    Foster, JA
    Marder, SR
    [J]. MAGNETIC RESONANCE IMAGING, 1997, 15 (01) : 29 - 35
  • [4] In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging
    Bartzokis, G
    Sultzer, D
    Cummings, J
    Holt, LE
    Hance, DB
    Henderson, VW
    Mintz, J
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2000, 57 (01) : 47 - 53
  • [5] IRON-SULFUR STOICHIOMETRY AND STRUCTURE OF IRON-SULFUR CLUSTERS IN 3-IRON PROTEINS - EVIDENCE FOR [3FE-4S] CLUSTERS
    BEINERT, H
    EMPTAGE, MH
    DREYER, JL
    SCOTT, RA
    HAHN, JE
    HODGSON, KO
    THOMSON, AJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (02): : 393 - 396
  • [6] Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats
    Ben Shachar, D
    Kahana, N
    Kampel, V
    Warshawsky, A
    Youdim, MBH
    [J]. NEUROPHARMACOLOGY, 2004, 46 (02) : 254 - 263
  • [7] Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad
  • [8] Heterogenous distribution of ferroportin-containing neurons in mouse brain
    Boserup, Michael W.
    Lichota, Jacek
    Haile, David
    Moos, Torben
    [J]. BIOMETALS, 2011, 24 (02) : 357 - 375
  • [9] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [10] Bradbury MWB, 1997, J NEUROCHEM, V69, P443